Home » Topics » BioWorld Science

BioWorld Science
RSS

Myungmoon Bio, Kyungpook National University disclose new anticancer compounds

Nov. 28, 2019

G12C-mutant GTPase KRAS inhibitors patented by Amgen

Nov. 28, 2019

Imago Biosciences describes new KDM1A inhibitors

Nov. 28, 2019

AstraZeneca identifies new TRPC3 and TRPC6 antagonists

Nov. 28, 2019

Identification of exosomal miRNAs as novel biomarkers and therapeutic targets in ADPKD

Nov. 28, 2019

Peroxiredoxin-1 as a novel therapeutic target in LPS-induced AKI

Nov. 28, 2019

Merck KGaA presents phase I data for the novel antimalarial candidate M-5717

Nov. 28, 2019

TMAO is associated with diffuse cardiac fibrosis in HIV-positive individuals

Nov. 28, 2019

Subcutaneous infliximab biosimilar approved in the E.U. for the treatment of RA

Nov. 28, 2019

Patient recruitment ongoing in phase I/II study of BTZ-043 in pulmonary tuberculosis

Nov. 28, 2019

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...